Thrombosis: A major contributor to global disease burden

Thrombosis and Haemostasis

Volumn 112, Issue 5, 2014, Pages 843-852

  Raskob, Gary ^a   Angchaisuksiri, P ^b   Blanco, A N ^c   Buller, H ^d   Gallus, A ^e   Hunt, B J ^f   Hylek, E M ^g   Kakkar, A ^h   Konstantinides, S V ⁱ   McCumber, M ^a   Ozaki, Y ^j   Wendelboe, A ^a   Weitz, J I ^k  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e FLINDERS MEDICAL CENTRE   (Australia)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

ⁱ JOHANNES GUTENBERG UNIVERSITY   (Germany)

^j UNIVERSITY OF YAMANASHI   (Japan)

^k MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

Ischaemic heart disease; Stroke; Thrombosis; Venous thromboembolism

Indexed keywords

AGING; ARTICLE; BRAIN ISCHEMIA; CATHETER INFECTION; CONSENSUS; DEATH; DISABILITY ADJUSTED LIFE YEAR; ETHNICITY; HEALTH CARE POLICY; HOSPITAL ACQUIRED PNEUMONIA; HOSPITALIZATION; HUMAN; INCIDENCE; INCOME; ISCHEMIC HEART DISEASE; LITERATURE; MORBIDITY; PREVALENCE; QUALITY OF LIFE; SYSTEMATIC REVIEW; THROMBOSIS; VENOUS THROMBOEMBOLISM; COHORT ANALYSIS; HEALTH; LIFE EXPECTANCY; MORTALITY; PULMONARY EMBOLISM; QUALITY ADJUSTED LIFE YEAR; VENOUS THROMBOSIS;

COHORT STUDIES; GLOBAL HEALTH; HUMANS; INCIDENCE; LIFE EXPECTANCY; PULMONARY EMBOLISM; QUALITY-ADJUSTED LIFE YEARS; THROMBOSIS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84908517909     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-08-0671     Document Type: Article

References (92)

1. Hunter DJ, Fineberg HV. Convergence to common purpose in global health. N Engl J Med 2014; 370: 1753-1755.
2. Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. Lancet 2013; 382: 1898-1955.
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
4. Horton R. GBD 2010: understanding disease, injury, and risk. Lancet 2012; 380: 2053-2054.
5. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet 2012; 380: 2063-2066.
6. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-2223.
7. Feigin V, Forouzanfar M, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383: 245-255.
8. Cohen AT, Agnelli G, Anderson FA, et al.; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
9. Yusuf HR, Tsai J, Atrash HK, et al. Venous thromboembolism in adult hospitalizations-United States, 2007-2009. MMWR Morb Mortal Wkly Rep 2012; 61: 401-404.
10. Kahn S, Lim W, Dunn AS, et al.; American College of Chest Physicians. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl):. e195S-226S.
11. Gould MK, Garcia DA, Wren SM, et al.; American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e227S-277S.
12. Falck-Yitter Y, Francis CW, Johanson NA, et al.; American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e278S-325S.
13. Nicolaides AN, Fareed J, Kakkar AK, et al. Prevention and treatment of venous thromboembolism-international consensus statement. Int Angiol 2013; 32: 111-260.
14. Hald EM, Enga KF, Lochen ML, et al. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study. J Am Heart Assoc 2014; 3: e000483.
15. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010; 121: 1896-1903.
16. Moretti AM., Tafuri S, Parisi D, et al. Epidemiology of pulmonary embolism in Apulia from analysis of current data. Monaldi Arch Chest Dis 2010; 73: 18-24.
17. Severinsen MT, Johnsen SP, Tjonneland A, et al. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J of Intern Med 2010; 21: 268-272.
18. Huerta C, Johansson S, Wallander MA, et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167: 935-943.
19. Naess IA., Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5: 692-699.
20. Guijarro R, San Roman CM, Perello JI, et al.; Efficiency Group of the Internal Medicine Services of Andalusia; Strategic Plan of SADEMI (Andalusia Society of Internal Medicine). A study of hospital discharges for venous thromboembolism in the south of Spain. An analysis of 19, 170 cases from a regional database from 1998 to 2001. Eur J Intern Med 2005; 16: 279-286.
21. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-660.
22. Nordstrom M, Lindblad B, Bergqvist D, et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155-160.
23. Kierkegaard A. Incidence of acute deep vein thrombosis in two districts: a phlebographic study. Acta Chir Scand 1980; 146: 267-269.
24. Tagalakis V, Patenaude V, Kahn SR, et al. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J of Med 2013; 126: 832. e13-21.
25. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171: 831-837.
26. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
27. Stein PD, Kayali F, Olson RE, et al. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004; 116: 435-442.
28. Janke RM, McGovern PG, Folsom AR. Mortality, hospital discharges, and case fatality for pulmonary embolism in the Twin Cities: 1980-1995. J Clin Epidemiol 2000; 53: 103-109.
29. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000; 85: 1334-1337.
30. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
31. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998; 128: 737-740.
32. Anderson FA Jr, Wheeler HB, Goldberg RJ., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
33. Shiraev TP, Omari A, Rushworth RL. Trends in pulmonary embolism morbidity and mortality in Australia. Thromb Res 2013; 132: 19-25.
34. Ho WK, Hankey GJ, Eikelboom JW. The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia. Med J Aust 2008; 189: 144-147.
35. Vazquez FJ, Posadas-Martinez ML, Vicens J, et al. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J 2013; 11: 16.
36. Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011; 9: 85-91.
37. Lee CH, Lin LJ, Cheng DL, et al. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost 2010; 8: 1515-1523.
38. Cheuk BL, Cheung GC, Cheng SW. Epidemiology of venous thromboembolism in a Chinese population. Br J Surg 2004; 91: 424-428.
39. Woo KS, Tse LK, Tse CY, et al. The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong. Int J of Cardiol 1988; 20: 373-380.
40. Kroger K, Moerchel C, Moysidis T, et al. Incidence rate of pulmonary embolism in Germany: data from the federal statistical office. J Thromb Thrombolysis 2010; 29: 349-353.
41. Deitelzweig SB., Johnson BH, Lin J, et al. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J of Hematol 2011; 86: 217-220.
42. Deitelzweig SB, Lin J, Johnson BH, Schulman KL. Venous thromboembolism in the US: does race matter? J Thrombosis Thrombolysis 2011; 31: 133-138.
43. Abdul Sultan A, Tata LJ, Grainge MJ, et al. The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative metaanalysis. PLoS One 2013; 8: e70310.
44. Kane EV, Calderwood C, Dobbie R, et al. A population-based study of venous thrombosis in pregnancy in Scotland 1980-2005. Eur J Obstet Gynecol Reprod Bio 2013; 169: 223-229.
45. Heyl PS, Sappenfield WM, Burch D, et al. Pregnancy-related deaths due to pulmonary embolism: findings from two state-based mortality reviews. Matern Child Health J 2013; 17: 1230-1235.
46. Virkus RA, Lokkegaard EC, Bergholt T, et al. Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study. Thromb Haemost 2011; 106: 304-309.
47. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010; 116: 1302-1309.
48. Sharma S, Monga D. Venous thromboembolism during pregnancy and the postpartum period: incidence and risk factors in a large Victorian health service. Aust NZ J Obstet Gynaecol 2008; 48: 44-49.
49. Samuelsson E, Hellgren M, Hogberg U. Pregnancy-related deaths due to pulmonary embolism in Sweden. Acta Obstet Gynecol Scand 2007; 86: 435-443.
50. Wen SW, Huang L, Liston R, et al.; Maternal Health Study Group, Canadian Perinatal Surveillance System. Severe maternal morbidity in Canada, 1991-2001. CMAJ 2005; 173: 759-764.
51. Fawcus SR., van Coeverden de Groot HA, Isaacs S. A 50-year audit of maternal mortality in the Peninsula Maternal and Neonatal Service, Cape Town (1953-2002). Br J Obstet Gynecol 2005; 112: 1257-1263.
52. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year populationbased study. Ann Intern Med 2005; 143: 697-706.
53. Sullivan EA, Ford JB, Chambers G, et al. Maternal mortality in Australia, 1973-1996. Aust NZ J Obstet Gynaecol 2004; 44: 452-457; discussion 377.
54. Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94: 595-599.
55. Santosa F, Moysidis T, Moerchel C, et al. Pulmonary embolism in young people. Trends in Germany from 2005 to 2011. Hamostaseologie 2014; 34: 88-92.
56. Reardon G, Pandya N, Nutescu EA, et al. Incidence of venous thromboembolism in nursing home residents. J Am Med Dir Assoc 2013; 14: 578-584.
57. Schmidt M, Johannesdottir SA, Lemeshow S, et al. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. Br Med J Open 2013; 3: e002698.
58. Sweetland S, Beral V, Balkwill A, et al.; Million Women Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost 2012; 10: 2277-2286.
59. Moysidis T, Kroger K, Moerchel C, et al. Pulmonary embolism in young males and females in Germany: data from the Federal Statistical Office. Blood Coagul Fibrinolysis 2010; 21: 511-515.
60. Lutsey PL, Virnig BA, Durham SB, et al. Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 2010; 100: 1506-1513.
61. Spannagl M, Heinemann LA, Dominh T, et al. Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study. Thromb J 2005; 3: 8.
62. Samuelsson E, Hagg S. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users. Acta Obstet Gynecol Scand 2004; 83: 674-681.
63. Mellemkjaer L, Sorensen HT, Dreyer L, et al. Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark, 1977-95. BMJ 1999; 319: 820-821.
64. Kniffin WD Jr, Baron JA, Barrett J, et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-866.
65. Gaborit FS, Overvad K, M. Norgaard M, Kristensen SR, Tjonneland A, Severinsen MT. Alcohol intake and risk of venous thromboembolism. A Danish follow-up study. Thromb Haemost 2013; 110: 39-45.
66. Kunisawa, S, Ikai H, Imanaka Y. Incidence and prevention of postoperative venous thromboembolism: are they meaningful quality indicators in Japanese health care settings? World J Surg 2012; 36: 280-6. Erratum in World J Surg 2012; 36: 278-279.
67. White RH, Dager WE, Zhou H, et al. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96: 267-273.
68. Beemath A, Skaf E, Stein PD. Pulmonary embolism as a cause of death in adults who died with heart failure. Am J of Cardiol 2006; 98: 1073-1075.
69. Petrauskiene V, Falk M, Waernbaum I, et al. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005; 48: 1017-1021.
70. Gomes JP, Shaheen WH, Truong SV, et al. Incidence of venous thromboembolic events among nursing home residents. J Gen Intern Med 2003; 18: 934-936.
71. Stein PD, Matta F, Yaekoub AY. Incidence of vena cava thrombosis in the United States. Am J Cardiol 2008; 102: 927-929.
72. Jha AK, Larizgoitia I, Audera-Lopez C, et al. The global burden of unsafe medical care: analytic modelling of observational studies. Br Med J Qual Saf 2013; 22: 809-815.
73. Access Economics Party Limited. The burden of venous thromboembolism in Australia. The Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism; 2008 May. 49 p.
74. Wilson RM, Michel P, Olsen S, et al.; WHO Patient Safety EMRO/AFRO Working Group. Patient safety in developing countries: retrospective estimation of scale and nature of harm to patients in hospital. Br Med J 2012; 344: e832.
75. Aranaz-Andres JM, Aibar-Remon C, Limon-Ramirez R, et al.; IBEAS team. Prevalence of adverse events in the hospitals of five Latin American countries: results of the 'Iberoamerican Study of Adverse Events' (IBEAS). BMJ Qual Saf 2011; 20: 1043-1051.
76. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010; 8: 2105-2112.
77. Angchaisuksiri P. Venous thromboembolism in Asia-an unrecognized and under-treated problem? Thromb Haemost 2011; 106: 585-590.
78. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vascular Biol 2008; 28: 3702.
79. Heit J, Cohen AT, Anderson FJ. Estimated annual number of incident and recurrent, fatal and non-fatal venous thromboembolism (VTE) events in the US. Blood 2005; 106: 267A.
80. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162: 1144-1148.
81. Kachroo S, Boyd D, Bookhart BK, et al. Quality of life and economic costs associated with postthrombotic syndrome. Am J Health Syst Pharm 2012; 69: 567-572.
82. Heit JA, Rooke TW, Silverstein MD, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg 2001; 33: 1022-1027.
83. Pengo V, Lensing AW, Prins MH, et al.; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
84. Noble S, Lewis R, Whithers J, et al. Long-term psychological consequences of symptomatic pulmonary embolism: a qualitative study. Br Med J Open 2014; 4: e004561.
85. Cohen AT, Spiro TE, Buller HR, et al.; MAGELLAN Investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 2013; 368: 513-523.
86. Goldhaber SZ, Leizorovicz A, Kakkar AK, et al.; ADOPT Trial Investigators. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 2011; 365: 2167-2177.
87. Raskob GE, Gallus AS, Pineo GF, et al. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: Pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br 2012; 94: 257-264.
88. Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism. J Am Med Assoc 2014; 311: 717-728.
89. Cohen AT, Tapson VF, Bergmann JF, et al.; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-394. Erratum in: Lancet 2008; 371: 1914.
90. Lester W, Freemantle N, Begaj I, et al. Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target. Heart 2013; 99: 1734-1739.
91. Catterick D, Hunt BJ. Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study. Blood Coagul Fibrinolysis 2014; Epub aheaed of print.
92. Sixty-sixth World Health Assembly. Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. May 27, 2013. http://apps. who. int/gb/ebwha/pdf_files/WHA66/A66_R10-en. pdf.